A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant

This publication has 23 references indexed in Scilit:

• Vaccination of Monkeys with RecombinantPlasmodium falciparumApical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria
  Infection and Immunity, 2002
• In Vitro Studies with RecombinantPlasmodium falciparumApical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response
  Infection and Immunity, 2002
• High-Level Expression of the Malaria Blood-Stage Vaccine CandidatePlasmodium falciparumApical Membrane Antigen 1 and Induction of Antibodies That Inhibit Erythrocyte Invasion
  Infection and Immunity, 2002
• Progress and challenges for malaria vaccines
  Nature, 2002
• The economic and social burden of malaria
  Nature, 2002
• Immunization with Parasite-Derived Apical Membrane Antigen 1 or Passive Immunization with a Specific Monoclonal Antibody Protects BALB/c Mice against Lethal Plasmodium yoelii yoelii YM Blood-Stage Infection
  Infection and Immunity, 2000
• Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi
  Vaccine, 1998
• Protective Immunity Induced in Squirrel Monkeys with Recombinant Apical Membrane Antigen-1 of Plasmodium fragile
  The American Journal of Tropical Medicine and Hygiene, 1994
• Structure of the apical membrane antigen I (AMA-1) of Plasmodium chabaudi
  Molecular and Biochemical Parasitology, 1989
• Integral membrane protein located in the apical complex of Plasmodium falciparum.
  Molecular and Cellular Biology, 1989